Spain · Delayed Price · Currency is EUR Facephi Biometria Statistics
Total Valuation
BME:FACE has a market cap or net worth of EUR 39.67 million. The enterprise value is 46.08 million.
| Market Cap | 39.67M |
| Enterprise Value | 46.08M |
Important Dates
The next estimated earnings date is Wednesday, November 25, 2026.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:FACE has 26.45 million shares outstanding. The number of shares has increased by 4.89% in one year.
| Current Share Class | 26.45M |
| Shares Outstanding | 26.45M |
| Shares Change (YoY) | +4.89% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 5.78% |
| Owned by Institutions (%) | 27.56% |
| Float | 23.17M |
Valuation Ratios
The trailing PE ratio is 124.61 and the forward PE ratio is 13.04. BME:FACE's PEG ratio is 0.20.
| PE Ratio | 124.61 |
| Forward PE | 13.04 |
| PS Ratio | 0.98 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 5.17 |
| P/FCF Ratio | 5.59 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.20 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.28, with an EV/FCF ratio of 6.49.
| EV / Earnings | 144.73 |
| EV / Sales | 1.13 |
| EV / EBITDA | 21.28 |
| EV / EBIT | 28.45 |
| EV / FCF | 6.49 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.40.
| Current Ratio | 1.12 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 4.02 |
| Debt / FCF | 1.23 |
| Interest Coverage | 1.92 |
Financial Efficiency
Return on equity (ROE) is 1.56% and return on invested capital (ROIC) is 5.75%.
| Return on Equity (ROE) | 1.56% |
| Return on Assets (ROA) | 2.07% |
| Return on Invested Capital (ROIC) | 5.75% |
| Return on Capital Employed (ROCE) | 7.06% |
| Weighted Average Cost of Capital (WACC) | 10.19% |
| Revenue Per Employee | 158,592 |
| Profits Per Employee | 1,244 |
| Employee Count | 256 |
| Asset Turnover | 0.83 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -40,171 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.41% in the last 52 weeks. The beta is 1.18, so BME:FACE's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -41.41% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.15 |
| Relative Strength Index (RSI) | 28.64 |
| Average Volume (20 Days) | 19,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:FACE had revenue of EUR 40.60 million and earned 318,368 in profits. Earnings per share was 0.01.
| Revenue | 40.60M |
| Gross Profit | 30.31M |
| Operating Income | 1.62M |
| Pretax Income | 278,197 |
| Net Income | 318,368 |
| EBITDA | 2.16M |
| EBIT | 1.62M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 2.30 million in cash and 8.70 million in debt, with a net cash position of -6.41 million or -0.24 per share.
| Cash & Cash Equivalents | 2.30M |
| Total Debt | 8.70M |
| Net Cash | -6.41M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 21.74M |
| Book Value Per Share | 0.82 |
| Working Capital | 3.01M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -204,169 |
| Depreciation & Amortization | 545,554 |
| Net Borrowing | n/a |
| Free Cash Flow | 7.10M |
| FCF Per Share | 0.27 |
Margins
Gross margin is 74.66%, with operating and profit margins of 3.99% and 0.78%.
| Gross Margin | 74.66% |
| Operating Margin | 3.99% |
| Pretax Margin | 0.69% |
| Profit Margin | 0.78% |
| EBITDA Margin | 5.33% |
| EBIT Margin | 3.99% |
| FCF Margin | 18.94% |
Dividends & Yields
BME:FACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.89% |
| Shareholder Yield | -4.89% |
| Earnings Yield | 0.80% |
| FCF Yield | 17.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:FACE has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 6 |